APA (7th ed.) Citation

Schwalbe, E. C., Lindsey, J. C., Danilenko, M., Hill, R. M., Crosier, S., Ryan, S., . . . Clifford, S. C. (2025). Molecular and clinical heterogeneity within MYC-family amplified medulloblastoma is associated with survival outcomes: A multicenter cohort study. Neuro-Oncology, 27(1), . https://doi.org/10.1093/neuonc/noae178

Chicago Style (17th ed.) Citation

Schwalbe, Edward C., et al. "Molecular and Clinical Heterogeneity Within MYC-family Amplified Medulloblastoma Is Associated with Survival Outcomes: A Multicenter Cohort Study." Neuro-Oncology 27, no. 1 (2025). https://doi.org/10.1093/neuonc/noae178.

MLA (9th ed.) Citation

Schwalbe, Edward C., et al. "Molecular and Clinical Heterogeneity Within MYC-family Amplified Medulloblastoma Is Associated with Survival Outcomes: A Multicenter Cohort Study." Neuro-Oncology, vol. 27, no. 1, 2025, https://doi.org/10.1093/neuonc/noae178.